Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) Return on Invested Capital (2019 - 2025)

Historic Return on Invested Capital for TransMedics (TMDX) over the last 7 years, with Q3 2025 value amounting to 0.28%.

  • TransMedics' Return on Invested Capital rose 1200.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.28%, marking a year-over-year increase of 1200.0%. This contributed to the annual value of 0.2% for FY2024, which is 3700.0% up from last year.
  • According to the latest figures from Q3 2025, TransMedics' Return on Invested Capital is 0.28%, which was up 1200.0% from 0.25% recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Return on Invested Capital peaked at 0.28% during Q3 2025, and registered a low of 0.76% during Q2 2022.
  • Its 5-year average for Return on Invested Capital is 0.16%, with a median of 0.17% in 2022.
  • In the last 5 years, TransMedics' Return on Invested Capital tumbled by -4700bps in 2022 and then skyrocketed by 6700bps in 2023.
  • Quarter analysis of 5 years shows TransMedics' Return on Invested Capital stood at 0.54% in 2021, then skyrocketed by 69bps to 0.17% in 2022, then decreased by -22bps to 0.2% in 2023, then skyrocketed by 183bps to 0.17% in 2024, then skyrocketed by 65bps to 0.28% in 2025.
  • Its Return on Invested Capital stands at 0.28% for Q3 2025, versus 0.25% for Q2 2025 and 0.21% for Q1 2025.